{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:51:24Z","timestamp":1793379084282,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council\u00c2\u00a0of\u00c2\u00a0Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["09\/015(0530)\/2018-EMR-I"],"award-info":[{"award-number":["09\/015(0530)\/2018-EMR-I"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015655","name":"Bose Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.intimp.2020.106932","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T08:12:06Z","timestamp":1599034326000},"page":"106932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Glycyrrhizic acid facilitates anti-tumor immunity by attenuating Tregs and MDSCs: An immunotherapeutic approach"],"prefix":"10.1016","volume":"88","author":[{"given":"Subir Kumar","family":"Juin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweta","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrata","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2020.106932_b0005","article-title":"Melanoma: from melanocyte to genetic alterations and clinical options","volume":"2013","author":"Bertolotto","year":"2013","journal-title":"Scientifica (Cairo)"},{"key":"10.1016\/j.intimp.2020.106932_b0010","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/858425","article-title":"Worldwide increasing incidences of cutaneous malignant melanoma","volume":"2011","author":"Godar","year":"2011","journal-title":"J. Skin Cancer"},{"key":"10.1016\/j.intimp.2020.106932_b0015","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/pon.4290","article-title":"Systematic review of psychosocial outcomes for patients with advanced melanoma","volume":"26","author":"Dunn","year":"2017","journal-title":"Psychooncology"},{"key":"10.1016\/j.intimp.2020.106932_b0020","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1002\/ijc.30630","article-title":"Niacin intake and risk of skin cancer in US women and men","volume":"140","author":"Park","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2020.106932_b0025","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/CMR.0000000000000339","article-title":"Interactions from complementary and alternative medicine in patients with melanoma","volume":"27","author":"Loquai","year":"2017","journal-title":"Melanoma Res."},{"key":"10.1016\/j.intimp.2020.106932_b0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/CMR.0000000000000158","article-title":"The cost of ipilimumab toxicity: a single-centre analysis","volume":"25","author":"Yousaf","year":"2015","journal-title":"Melanoma Res."},{"key":"10.1016\/j.intimp.2020.106932_b0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fimmu.2015.00046","article-title":"Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment","volume":"6","author":"Aris","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2020.106932_b0040","first-page":"184","article-title":"Cost-effectiveness of pembrolizumab versus ipilimumab in ipilimumab-na\u00efve patients with advanced melanoma in the United States","volume":"23","author":"Wang","year":"2017","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"10.1016\/j.intimp.2020.106932_b0045","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/978-3-642-38007-5_25","article-title":"Novel approaches in melanoma prevention and therapy","volume":"159","author":"Grimaldi","year":"2014","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.intimp.2020.106932_b0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/ITT.S134842","article-title":"Melanoma treatment in review","volume":"7","author":"Domingues","year":"2018","journal-title":"Immunotargets Ther."},{"key":"10.1016\/j.intimp.2020.106932_b0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jaad.2014.01.910","article-title":"Nutrition: the future of melanoma prevention?","volume":"71","author":"Tong","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2020.106932_b0060","doi-asserted-by":"crossref","first-page":"11679","DOI":"10.3390\/molecules190811679","article-title":"Review of natural compounds for potential skin cancer treatment","volume":"19","author":"Chinembiri","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2020.106932_b0065","first-page":"589","article-title":"Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots","volume":"6","author":"Suzuki","year":"1992","journal-title":"Vivo"},{"key":"10.1016\/j.intimp.2020.106932_b0070","first-page":"91","article-title":"In vitro antiviral activity of indigenous glycyrrhizin, licorice and glycyrrhizic acid (Sigma) on Japanese encephalitis virus","volume":"29","author":"Badam","year":"1997","journal-title":"J. Commun. Dis."},{"key":"10.1016\/j.intimp.2020.106932_b0075","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/jac\/dks159","article-title":"Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection","volume":"67","author":"Bhattacharjee","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.intimp.2020.106932_b0080","first-page":"703","article-title":"Glycyrrhizic acid induces human MDA-MB-231 breast cancer cell death and autophagy via the ROS-mitochondrial pathway","volume":"39","author":"Lin","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2020.106932_b0085","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1128\/IAI.00528-16","article-title":"Leishmania donovani-induced prostaglandin E2 generation is critically dependent on host toll-like receptor 2-cytosolic phospholipase A2 signaling","volume":"84","author":"Bhattacharjee","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2020.106932_b0090","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1128\/IAI.00729-15","article-title":"Glycyrrhizic acid-mediated subdual of myeloid-derived suppressor cells induces antileishmanial immune responses in a susceptible host","volume":"83","author":"Bandyopadhyay","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2020.106932_b0095","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12935-015-0260-7","article-title":"Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity","volume":"15","author":"Liu","year":"2015","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.intimp.2020.106932_b0100","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0016-5085(94)90246-1","article-title":"Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas","volume":"107","author":"Eberhart","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2020.106932_b0105","first-page":"987","article-title":"Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer","volume":"59","author":"Tucker","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2020.106932_b0110","first-page":"3761","article-title":"Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas","volume":"58","author":"Hida","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2020.106932_b0115","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(00)81433-6","article-title":"Cyclooxygenase regulates angiogenesis induced by colon cancer cells","volume":"93","author":"Tsujii","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2020.106932_b0120","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0092-8674(95)90127-2","article-title":"Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2","volume":"83","author":"Tsujii","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2020.106932_b0125","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1002\/cncr.24999","article-title":"Intratumoral forkhead box P3-positive regulatory T cells predict poor survival in cyclooxygenase-2-positive uveal melanoma","volume":"116","author":"Mougiakakos","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.intimp.2020.106932_b0130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jss.2007.03.053","article-title":"Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells","volume":"141","author":"Baumgartner","year":"2007","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.intimp.2020.106932_b0135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clim.2009.10.005","article-title":"Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner","volume":"134","author":"Yuan","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2020.106932_b0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1158\/0008-5472.CAN-17-0348","article-title":"CCR5(+) myeloid-derived suppressor cells are enriched and activated in melanoma lesions","volume":"78","author":"Blattner","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2020.106932_b0145","doi-asserted-by":"crossref","first-page":"17111","DOI":"10.1073\/pnas.1108121108","article-title":"Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model","volume":"108","author":"Meyer","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2020.106932_b0150","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2020.106932_b0155","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1172\/JCI60083","article-title":"STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients","volume":"123","author":"Vasquez-Dunddel","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2020.106932_b0160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.26307","article-title":"The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models","volume":"131","author":"Hatiboglu","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2020.106932_b0165","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10555-005-1580-1","article-title":"Targeting STAT3 affects melanoma on multiple fronts","volume":"24","author":"Kortylewski","year":"2005","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.intimp.2020.106932_b0170","first-page":"5059","article-title":"Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo","volume":"59","author":"Niu","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2020.106932_b0175","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.biopha.2013.03.020","article-title":"Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway","volume":"67","author":"Kamran","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2020.106932_b0180","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nri1668","article-title":"Regulation of immune responses by L-arginine metabolism","volume":"5","author":"Bronte","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2020.106932_b0185","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1084\/jem.20050715","article-title":"Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma","volume":"202","author":"Rodriguez","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2020.106932_b0190","unstructured":"S. Majumdar, A process for isolating and purifying glycyrrhizic acid (Glycyrrhiza glabra) roots effective against leishmaniasis and composition containing the same. Indian patent application 771\/KOL\/2005. International classification no. A61K\/31\/00, 2006. Government of India, New Delhi, India, 2005. http:\/\/www.allindianpatents.com\/patents\/236432-a-process-for-isolating-and-purifying-glycyrrhizic-acid-glycyrrhiza-glabra-roots-effective-against-leishmaniasis-and-composition-containing-the-same."},{"key":"10.1016\/j.intimp.2020.106932_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091656","article-title":"Overexpressed PKC\u03b4 downregulates the expression of PKC\u03b1 in B16F10 melanoma: induction of apoptosis by PKC\u03b4 via ceramide generation","volume":"9","author":"Halder","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2020.106932_b0200","doi-asserted-by":"crossref","first-page":"37627","DOI":"10.18632\/oncotarget.26478","article-title":"TNF\u03b1 mediated ceramide generation triggers cisplatin induced apoptosis in B16F10 melanoma in a PKC\u03b4 independent manner","volume":"9","author":"Ghosh","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2020.106932_b0205","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.intimp.2020.106932_b0210","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2020.106932_b0215","first-page":"1085","article-title":"Hormonal influences on growth of B16 murine melanoma","volume":"74","author":"Simon","year":"1985","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.intimp.2020.106932_b0220","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1080\/15384047.2015.1078024","article-title":"Mycobacterium indicus pranii (Mw) inhibits invasion by reducing matrix metalloproteinase (MMP-9) via AKT\/ERK-1\/2 and PKC\u03b1 signaling: a potential candidate in melanoma cancer therapy","volume":"18","author":"Halder","year":"2017","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.intimp.2020.106932_b0225","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2014.995559","article-title":"The combination of a novel immunomodulator with a regulatory T cell suppressing antibody (DTA-1) regress advanced stage B16F10 solid tumor by repolarizing tumor associated macrophages in situ","volume":"4","author":"Banerjee","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2020.106932_b0230","doi-asserted-by":"crossref","first-page":"ftv063","DOI":"10.1093\/femspd\/ftv063","article-title":"Immunomodulation of host-protective immune response by regulating Foxp3 expression and Treg function in Leishmania-infected BALB\/c mice: critical role of IRF1","volume":"73","author":"Chowdhury","year":"2015","journal-title":"Pathog Dis"},{"key":"10.1016\/j.intimp.2020.106932_b0235","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1365-2567.2001.01243.x","article-title":"Upregulation of CD4 on CD8+ T cells: CD4dimCD8bright T cells constitute an activated phenotype of CD8+ T cells","volume":"103","author":"Sullivan","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2020.106932_b0240","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1006\/cyto.1999.0614","article-title":"Autocrine and paracrine regulation by cytokines and growth factors in melanoma","volume":"12","author":"L\u00e1z\u00e1r-Moln\u00e1r","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2020.106932_b0245","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3390\/cancers2020794","article-title":"Cytokines and growth factors expressed by human cutaneous melanoma","volume":"2","author":"Elias","year":"2010","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2020.106932_b0250","first-page":"3856","volume":"3","author":"Lee","year":"2011","journal-title":"Cytokines in cancer immunotherapy. Cancers (Basel)"},{"key":"10.1016\/j.intimp.2020.106932_b0255","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.169.5.2756","article-title":"Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma","volume":"169","author":"Liyanage","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2020.106932_b0260","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/CMR.0b013e32831d7f52","article-title":"COX-2 expression in malignant melanoma: a novel prognostic marker?","volume":"19","author":"Becker","year":"2009","journal-title":"Melanoma Res."},{"key":"10.1016\/j.intimp.2020.106932_b0265","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00262-011-1025-3","article-title":"Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction","volume":"60","author":"Niu","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2020.106932_b0270","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2020.106932_b0275","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood-2006-02-002774","article-title":"Regulatory T cells in cancer","volume":"108","author":"Beyer","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2020.106932_b0280","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ni759","article-title":"Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance","volume":"3","author":"Shimizu","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2020.106932_b0285","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1084\/jem.192.2.295","article-title":"Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation","volume":"192","author":"Read","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2020.106932_b0290","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2020.106932_b0295","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2020.106932_b0300","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/bs.acr.2015.04.002","article-title":"Myeloid-derived suppressor cells: critical cells driving immune suppression in the tumor microenvironment","volume":"128","author":"Parker","year":"2015","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.intimp.2020.106932_b0305","first-page":"35","article-title":"MDSCs in cancer: conceiving new prognostic and therapeutic targets","volume":"1865","author":"De Sanctis","year":"2016","journal-title":"Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids"},{"key":"10.1016\/j.intimp.2020.106932_b0310","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/ijc.26099","article-title":"Immunotherapeutic efficacy of Mycobacterium indicus pranii in eliciting anti-tumor T cell responses: critical roles of IFN\u03b3","volume":"130","author":"Rakshit","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2020.106932_b0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025424","article-title":"Activation of anti-tumor immune response and reduction of regulatory T cells with Mycobacterium indicus pranii (MIP) therapy in tumor bearing mice","volume":"6","author":"Ahmad","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2020.106932_b0320","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00262-020-02492-0","article-title":"PKC\u03b6 mediated anti-proliferative effect of C2 ceramide on neutralization of the tumor microenvironment and melanoma regression","volume":"69","author":"Ghosh","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2020.106932_b0325","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.canlet.2013.02.056","article-title":"Emerging phytochemicals for prevention of melanoma invasion","volume":"335","author":"Jones","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2020.106932_b0330","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/CMR.0b013e3283456dfc","article-title":"Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt\/PKB","volume":"21","author":"Bhattacharya","year":"2011","journal-title":"Melanoma Res."},{"issue":"218\u201320","key":"10.1016\/j.intimp.2020.106932_b0335","article-title":"Cancer chemopreventive activity of resveratrol, a natural product derived from grapes","volume":"275","author":"Jang","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.intimp.2020.106932_b0340","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3892\/or.2015.4413","article-title":"Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT\/mTOR signaling pathway in human melanoma cells","volume":"35","author":"Zhao","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2020.106932_b0345","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.canlet.2015.11.032","article-title":"Resveratrol triggers ER-stress mediated apoptosis by disrupting N-linked glycosylation of proteins in ovarian cancer cells","volume":"371","author":"Gwak","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2020.106932_b0350","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1111\/cas.13720","article-title":"Resveratrol ameliorates Lewis lung carcinoma-bearing mice development, decreases granulocytic myeloid-derived suppressor cell accumulation and impairs its suppressive ability","volume":"109","author":"Zhao","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.intimp.2020.106932_b0355","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.intimp.2007.12.006","article-title":"Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells","volume":"8","author":"Yang","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2020.106932_b0360","article-title":"Glycyrrhizic acid suppresses the development of precancerous lesions via regulating the hyperproliferation, inflammation, angiogenesis and apoptosis in the colon of Wistar rats","volume":"8","author":"Khan","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2020.106932_b0365","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/carcin\/20.1.59","article-title":"Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice","volume":"20","author":"Shiota","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.intimp.2020.106932_b0370","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/01635589109514126","article-title":"Inhibition of mouse skin tumor-initiating activity of DMBA by chronic oral feeding of glycyrrhizin in drinking water","volume":"15","author":"Agarwal","year":"1991","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.intimp.2020.106932_b0375","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1248\/yakushi1947.108.8_794","article-title":"Inhibitory effect of glycyrrhizin and caffeine on two-stage carcinogenesis in mice","volume":"108","author":"Yasukawa","year":"1988","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.intimp.2020.106932_b0380","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2020.106932_b0385","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1038\/onc.2008.307","article-title":"Bcl-2 family proteins and cancer","volume":"27","author":"Yip","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2020.106932_b0390","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood.V91.8.2991.2991_2991_2997","article-title":"Hematopoietic malignancies demonstrate loss-of-function mutations of BAX","volume":"91","author":"Meijerink","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2020.106932_b0395","first-page":"159","article-title":"Malignant melanoma associates with Th1\/Th2 imbalance that coincides with disease progression and immunotherapy response","volume":"49","author":"Lauerova","year":"2002","journal-title":"Neoplasma"},{"key":"10.1016\/j.intimp.2020.106932_b0400","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41419-017-0059-7","article-title":"Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies","volume":"9","author":"Mattia","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2020.106932_b0405","first-page":"118","article-title":"Role of mycobacterium w as adjuvant treatment of lung cancer (non-small cell lung cancer)","volume":"101","author":"Sur","year":"2003","journal-title":"J. Indian Med. Assoc."},{"key":"10.1016\/j.intimp.2020.106932_b0410","first-page":"559","article-title":"Bladder preserving approach for muscle invasive bladder cancer-role of mycobacterium w","volume":"101","author":"Chaudhuri","year":"2003","journal-title":"J. Indian Med. Assoc."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920310456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920310456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:47:27Z","timestamp":1762552047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920310456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":82,"alternative-id":["S1567576920310456"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106932","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycyrrhizic acid facilitates anti-tumor immunity by attenuating Tregs and MDSCs: An immunotherapeutic approach","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106932"}}